Table 1.
Demographic and Laboratory Data of Our Ischemic Stroke Patients and Control Subjects
| Variables | Stroke Patients (n= 46) | Control Subjects (n= 50) | P value |
|---|---|---|---|
| Age (years) | 58.3 ± 2.1 | 56.8 ± 3.1 | 0.08 |
| SBP (mmHg) | 146.5 ± 3.03 | 118 ± 2.4 | 0.01* |
| DBP (mmHg) | 88.2 ± 1.8 | 75.7 ± 2.02 | 0.04* |
| Duration of stroke (hrs) | 3.4 ± 0.12 | —– | – |
| FBS (mg/dl) | 142 ± 2.8 | 105.5 ± 1.9 | 0.0001* |
| TC (mg/dl) | 176.4 ± 8.8 | 155.2 ± 5.6 | 0.02* |
| TG (mg/dl) | 161.7 ± 6.5 | 158.3 ± 5.2 | 0.7 |
| LDL –C (mg/dl) | 113.7 ± 7.5 | 95.2 ± 4.2 | 0.02* |
| HDL- C (mg/dl) | 29.9 ± 1.4 | 28.6 ± 1.6 | 0.6 |
| Hemoglobin (gm/dl) | 9.5 ± 0.2 | 10.4 ± 0.16 | 0.0006* |
| TLC (×103/microl) | 10.1 ± 0.69 | 7.3 ± 0.7 | 0.005* |
| Platelets (×103/microl) | 247.5 ± 11.2 | 241.5 ± 13.8 | 0.9 |
| ESR mm/hr | 55.2 ± 3.5 | 22.1 ± 1.2 | 0.0001* |
| Ejection fraction % | 53.8 ± 2.9 | NA | - |
| Diabetes mellitus | 9 (19.6%) | ——- | ——- |
| Hypertension | 19 (41.3%) | ——- | ——- |
| Smoking | 14 (30%) | ——- | ——- |
| Drug abuse | 2 (4%) | ——- | ——- |
| Stroke recurrence | 6 (13%) | ||
| Atrial fibrillation | 4 (9%) | ——– | ——- |
| Carotid atherosclerosis | 27 (59%) | NA | ——– |
| Significant carotid stenosis | 7 (15%) | NA | ——– |
Notes: Data are presented as mean ±SE; *P < 0.05 was considered statistically significant.
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure; NA, not available; FBS, fasting blood sugar; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TLC, total leucocytic count; ESR, estimated sedimentation rate.